Clinical features and global epidemiological analysis of sparganosis: Based on 5 pediatric cases and a systematic review of 135 literature reports.
- 1Department of Nephrology & Rheumatology, Kunming Children's Hospital (Kunming Children's Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, 650228, China.
- 2Department of Nephrology & Rheumatology, Kunming Children's Hospital (Kunming Children's Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, 650228, China. [email protected].
- 3Department of Nephrology & Rheumatology, Kunming Children's Hospital (Kunming Children's Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, 650228, China. [email protected].
Abstract
Objective Sparganosis is a rare parasitic disease caused by the larvae of Spirometra mansoni, with pediatric cases being particularly uncommon and prone to misdiagnosis. This study aims to analyze the clinical features, diagnostic strategies, and treatment responses in pediatric sparganosis, and to investigate its global epidemiological trends and diagnostic and therapeutic advancements through a systematic review. Methods We conducted a retrospective analysis of 5 confirmed pediatric sparganosis cases admitted to our center between 2014 and 2023. A systematic search of the PubMed database (1980-2025) for relevant literature was performed, leading to the screening and data extraction of 135 global case reports. Descriptive statistics, correlation analysis, and trend visualization were conducted using R software (version 4.5.1). Results Among the 5 children in our center, the median age was 7 years, and all were from high-parasitic-endemicity areas in Yunnan Province, China. All cases (100%) presented with marked eosinophilia (median value 4.42 × 10⁹/L). Neurological involvement was predominant (60%, 3/5), manifesting as epilepsy, myelitis, etc. All patients received praziquantel treatment, with four also receiving concomitant corticosteroids, and all showed symptom improvement. Analysis of global cases revealed a geographic clustering in East Asia (primarily China, South Korea, Japan, and Thailand), with the central nervous system and subcutaneous tissue being the two major infection sites. Diagnosis relied mainly on MRI ("tunnel sign"), serological testing, and metagenomic Next-Generation Sequencing (mNGS). The highest improvement rate (92.2%) was observed with combination therapy (surgery plus medication), which yielded comparably high improvement rates to single-modality treatments. Conclusion Pediatric sparganosis predominantly involves the nervous system. Diagnosis requires integrating epidemiological history, imaging, and molecular testing. Treatment should be individualized, with a recommended regimen of surgery combined with long-term, weight-based praziquantel therapy, supplemented by corticosteroids when necessary. Strengthening public health education remains the fundamental measure for preventing this disease.
Related
- Clinical-Epidemiological, Trichoscopic, and Light Microscopic Evaluation of Pediatric Hair and Scalp Disorders: A Cross-Sectional Study from a Tertiary Care Hospital.
- Ten-year epidemiological and clinical insights of pediatric influenza A and B hospitalizations: an observational study
- Clinical Presentation of, Treatment Approaches for, and the Impact of Social Determinants of Health on Pediatric Catatonia: A Structured Qualitative Synthesis and Targeted Literature Review.
- Clinical Management of Pediatric Hemosuccus Pancreaticus: Experience Based on a Case Report and Mini Literature Review
- Clinical and epidemiological aspects of coinfection with American tegumentary leishmaniasis and HIV/AIDS in South American countries: a systematic review.
BibTeX
@article{zhang2026clinical,
title = {{Clinical features and global epidemiological analysis of sparganosis: Based on 5 pediatric cases and a systematic review of 135 literature reports.}},
author = {Jia Zhang and Yingyi Zhang and Helin Yan and Hongye Wang and Yangmengqian Zhou and Bo Zhao and Mifeng Yang},
journal = {Parasitology research},
year = {2026},
month = sep,
doi = {10.1007/s00436-026-08746-7},
url = {https://europepmc.org/article/MED/42905153},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Clinical features and global epidemiological analysis of sparganosis: Based on 5 pediatric cases and a systematic review of 135 literature reports.
AU - Jia Zhang
AU - Yingyi Zhang
AU - Helin Yan
AU - Hongye Wang
AU - Yangmengqian Zhou
AU - Bo Zhao
AU - Mifeng Yang
PY - 2026
DA - 2026/09/01
JO - Parasitology research
DO - 10.1007/s00436-026-08746-7
UR - https://europepmc.org/article/MED/42905153
AB - Objective Sparganosis is a rare parasitic disease caused by the larvae of Spirometra mansoni, with pediatric cases being particularly uncommon and prone to misdiagnosis. This study aims to analyze the clinical features, diagnostic strategies, and treatment responses in pediatric sparganosis, and to investigate its global epidemiological trends and diagnostic and therapeutic advancements through a systematic review. Methods We conducted a retrospective analysis of 5 confirmed pediatric sparganosis cases admitted to our center between 2014 and 2023. A systematic search of the PubMed database (1980-2025) for relevant literature was performed, leading to the screening and data extraction of 135 global case reports. Descriptive statistics, correlation analysis, and trend visualization were conducted using R software (version 4.5.1). Results Among the 5 children in our center, the median age was 7 years, and all were from high-parasitic-endemicity areas in Yunnan Province, China. All cases (100%) presented with marked eosinophilia (median value 4.42 × 10⁹/L). Neurological involvement was predominant (60%, 3/5), manifesting as epilepsy, myelitis, etc. All patients received praziquantel treatment, with four also receiving concomitant corticosteroids, and all showed symptom improvement. Analysis of global cases revealed a geographic clustering in East Asia (primarily China, South Korea, Japan, and Thailand), with the central nervous system and subcutaneous tissue being the two major infection sites. Diagnosis relied mainly on MRI ("tunnel sign"), serological testing, and metagenomic Next-Generation Sequencing (mNGS). The highest improvement rate (92.2%) was observed with combination therapy (surgery plus medication), which yielded comparably high improvement rates to single-modality treatments. Conclusion Pediatric sparganosis predominantly involves the nervous system. Diagnosis requires integrating epidemiological history, imaging, and molecular testing. Treatment should be individualized, with a recommended regimen of surgery combined with long-term, weight-based praziquantel therapy, supplemented by corticosteroids when necessary. Strengthening public health education remains the fundamental measure for preventing this disease.
SN - 0932-0113
SN - 1432-1955
ER -